Markets:

Overview

News

Currencies

International

Treasuries

SELLAS Life Sciences Group, Inc. - Common Stock (NQ:SLS)

4.040 -0.060 (-1.46%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SELLAS Life Sciences Group, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

November 07, 2022

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Via Benzinga

Why FAT Brands Shares Are Trading Sharply Lower; Here Are 24 Stocks Moving Premarket ↗

November 07, 2022

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares rose 39.5% to $24.39 in pre-market trading following recent reports that Donald Trump could soon announce 2024 Presidential run.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 11, 2022

On Wednesday, 807 companies reached new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

April 08, 2022

During Friday's morning session, 234 stocks hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company in terms of market cap...

Via Benzinga

Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday ↗

October 26, 2022

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 18, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 12, 2022

Gainers Adamis Pharmaceuticals (NASDAQ:ADMP) shares moved upwards by 28.1% to $0.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $28.1 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 12, 2022

It's time for another dive into the biggest pre-market stock movers as we check out what's behind shares moving on Wednesday!

Via InvestorPlace

SELLAS Life Sciences Touts Encouraging Preclinical Data For Candidate For Aggressive Form Of Prostate Cancer ↗

August 24, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 21, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 18, 2022

Gainers Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 13, 2022

Gainers

Via Benzinga

SELLAS Life Sciences's Galinpepimut/Opdivo Combo Shows Increased Survival In Mesothelioma Patients ↗

June 08, 2022

Via Benzinga

Sellas' Ovarian Cancer Candidate Shows Clinical Benefit In Pretreated Patients ↗

May 26, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

May 19, 2022

It's time to tackle the biggest pre-market stock movers for this morning as we get ready for trading hours to start on Thursday!

Via InvestorPlace

93 Biggest Movers From Yesterday ↗

June 14, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in...

Via Benzinga

70 Stocks Moving In Monday's Mid-Day Session ↗

June 13, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric...

Via Benzinga

Week In Review: Harbour BioMed Signs $350 Million Out-license Deal For Bispecific With AstraZeneca ↗

April 09, 2022

Harbour BioMed out-licensed global rights for a pre-clinical bispecific candidate to AstraZeneca in a $350 million agreement. Harbour BioMed will receive $25 million upfront and as much as $325 million...

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For April 14, 2022 ↗

April 14, 2022

Upgrades

Via Benzinga

The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy ↗

April 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 06, 2022

Good morning! Another day of trading lies ahead and we're starting it off with the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

55 Biggest Movers From Friday ↗

April 04, 2022

Gainers Takung Art Co., Ltd. (NASDAQ: TKAT) surged 61.8% to close at $3.64 on Friday. Chicken Soup for the Soul Entertainment, Inc. (NASDAQ: CSSE) rose 43.8% to settle at $11.49...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Turns Lower; Chicken Soup for the Soul Entertainment Shares Spike Higher ↗

April 01, 2022

U.S. stocks pared gains, with the Nasdaq Composite turning lower toward the end of trading on Friday.

Via Benzinga

Mid-Day Market Update: Gold Drops Over 1%; Manning & Napier Shares Jump ↗

April 01, 2022

U.S. stocks traded slightly higher midway through trading following the release of non-farm payroll data for March.

Via Benzinga

38 Stocks Moving In Friday's Mid-Day Session ↗

April 01, 2022

Gainers Manning & Napier, Inc. (NYSE: MN) jumped 40.7% to $12.82 after the company reported it will be acquired by Callodine Group and will go private at $12.85 per share....

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

April 01, 2022

On Friday, 111 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Citigroup (...

Via Benzinga

Mid-Morning Market Update: Markets Higher; US Economy Adds 431,000 Jobs In March ↗

April 01, 2022

U.S. stocks opened higher this morning following the release of non-farm payroll data for March.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 01, 2022

Gainers Yumanity Therapeutics (NASDAQ:YMTX) shares rose 13.3% to $1.7 during Friday's pre-market session. The market value of their outstanding shares is at $18.4...

Via Benzinga

The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study ↗

April 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

SELLAS Life Sciences Stock Plunges After $25M Capital Raise Via Equity, In-Licenses Cancer-Focused CDK9 Inhibitor ↗

April 01, 2022

GenFleet Therapeutics

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.